Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

NCT03453528 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1225

Enrollment

OTHER

Sponsor class

Conditions

Prostate-specific Membrane Antigen
mCRPC or Advanced/Metastatic Solid Tumors

Interventions

DRUG: 68Ga-PSMA

Sponsor

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS